ARS Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
ARS Pharmaceuticals, Inc. (SPRY) had Shares Outstanding (Cover Page) of 99.45 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 99.45M shares.
- 2026-05-13: Entity Common Stock, Shares Outstanding 99.30M shares.
- 2026-03-04: Entity Common Stock, Shares Outstanding 99.30M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 98.85M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 99.45M shares 10-Q · filed 2026-08-13 |
| 2026-05-13 | 99.30M shares 10-Q · filed 2026-05-15 |
| 2026-03-04 | 99.30M shares 10-K · filed 2026-03-09 |
| 2025-11-06 | 98.85M shares 10-Q · filed 2025-11-10 |
| 2025-08-11 | 98.83M shares 10-Q · filed 2025-08-13 |
| 2025-05-12 | 98.21M shares 10-Q · filed 2025-05-14 |
| 2025-03-17 | 98.12M shares 10-K · filed 2025-03-20 |
| 2024-11-06 | 97.19M shares 10-Q/A · filed 2024-12-06 |
| 2024-08-02 | 96.94M shares 10-Q · filed 2024-08-06 |
| 2024-05-06 | 96.90M shares 10-Q · filed 2024-05-09 |
| 2024-03-18 | 96.50M shares 10-K · filed 2024-03-21 |
| 2023-11-06 | 96.00M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 95.57M shares 10-Q · filed 2023-08-10 |
| 2023-05-10 | 94.77M shares 10-Q · filed 2023-05-15 |
| 2023-03-17 | 94.40M shares 10-K · filed 2023-03-23 |
| 2022-10-31 | 36.06M shares 10-Q · filed 2022-11-02 |
| 2022-08-08 | 35.47M shares 10-Q · filed 2022-08-11 |
| 2022-05-09 | 35.15M shares 10-Q · filed 2022-05-12 |
| 2022-03-28 | 35.14M shares 10-K · filed 2022-03-31 |
| 2021-11-08 | 35.08M shares 10-Q · filed 2021-11-10 |
| 2021-08-10 | 35.04M shares 10-Q · filed 2021-08-12 |
| 2021-05-10 | 34.91M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |